Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di S Regulatory News (MYXR)

  • There is currently no data for MYXR

Trading Statement

9 May 2012 07:00

RNS Number : 9307C
MyCelx Technologies Corporation
09 May 2012
 

Not for release, publication or distribution directly or indirectly, in whole or in part, in or into or from the United States of America (including its territories and possessions, any state of the United States, and the District of Columbia), Canada, Australia, the Republic of South Africa, the Republic of Ireland or Japan, or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

This press release does not constitute or form a part of, and should not be construed as, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities in MyCelx Technologies Corporation ("MyCelx" or the "Company").

THE COMPANY'S COMMON SHARES HAVE NOT BEEN REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE "US SECURITIES ACT") OR ANY STATE SECURITIES LAWS (THE "STATE ACTS") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS THE SECURITIES ARE REGISTERED UNDER THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS IS AVAILABLE.

 

MyCelx Technologies Corporation

("MyCelx" or the "Company") (AIM: MYX)

9 May 2012

Trading Statement

MyCelx Technologies, Inc (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, announces an update on trading in 2012. Progress has continued during the first half of the year, in particular with the securing, as announced on 23 April 2012, of two major separate Purchase Orders totalling US$2.65 million from the Middle East and India, both for delivery and installation during the current financial year. The Company continues to trade in line with management's expectations with continued sales to new as well as existing customers.

In addition, the Company has increased production capability in order to meet demand through adding warehouse and storage space, and appointing additional fabricators to accelerate equipment time tables.

In April 2012, the Company opened a new office and warehouse with additional personnel in Jubail Industrial City, Kingdom of Saudi Arabia, to service customers in that region. The Company has also made its first hire in Houston, USA to manage the Company's interface with global EPCs and as well as manage projects in the Gulf of Mexico.

The Company also announces that David Pattillo, who has served as a Director and Chief Financial Officer, has decided to step down from these positions with effect from 31 May 2012. Mr. Pattillo initiated and led the Company through its successful IPO on AIM in August 2011.The Board is delighted that David has agreed to stay on with the Company to work on specific priority projects and initiatives. The Board is grateful to David for the insight and leadership he provided during a critical period of the Company's growth.

Mark Clark, who is currently Financial Controller and joined MyCelx in October 2011 following a 14 year career at Invesco, has been appointed as Interim Chief Financial Officer with effect from 31 May 2012. The Board expects to make an appointment to the role of Chief Financial Officer in due course.

 

 

For further information please contact:

MyCelx Technologies Corporation

Connie Mixon, CEO

David Pattillo, CFO

Tel: +1 888 306 6843

 

Numis Securities Limited

Corporate Finance 

Alastair Stratton

Stuart Skinner

Jamie Loughborough

 

Corporate Broking

James Black

Ben Stoop

Tel: +44 20 7260 1000

 

Pelham Bell Pottinger

Mark Antelme

Nick Lambert

Henry Lerwill

Tel: +44 20 7861 3232

 

Notes for Editors

 

·; MyCelx Technologies Corporation is a clean water technology company that provides novel water treatment solutions to the oil and gas, power, marine and heavy manufacturing sectors

 

·; MyCelx invented and is the owner of the MyCelx polymer which is infused in the consumable media contained in equipment supplied by the Company

 

·; The technology produces treatment results that compare favourably to existing competition in effectiveness, cost and footprint. The MyCelx polymer and its use are protected by patents and other intellectual property rights

 

·; The defining difference of the MyCelx polymer as compared with alternative technologies currently available is that it is capable of permanently and reliably removing free, emulsified and dissolved hydrocarbons from water upon contact to levels between 0-10 parts per million (ppm) at any flow rate

 

·; MyCelx equipment has been installed successfully at the facilities of leading industry operators around the globe. The focus of the Company is now directed at the commercial application of MyCelx solutions in both upstream and downstream markets in the oil and gas industry

 

·; Over the last three years, the Company has sold its products primarily in North America, Asia, Australia, Middle East and Europe. Customers include such oil and gas companies as Chevron, BP, Anadarko Petroleum Corporation, SABIC, engineering, procurement and construction companies such as Mustang Engineering and global water treatment companies

 

·; Further information on MyCelx Technologies Corporation can be found at www.mycelx.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFBLEFLBBF
Date   Source Headline
13th Jul 20164:21 pmRNSResult of AGM
11th Jul 20167:00 amRNSHalf Year Trading Update
30th Jun 20167:00 amRNSHolding(s) in Company
24th Jun 20167:00 amRNSMyCelx and Schlumberger Sign Upstream Agreement
9th Jun 20167:00 amRNSMailing of 2015 Annual Report and Notice of AGM
7th Jun 20163:32 pmRNSBlock listing Interim Review
17th May 20167:00 amRNSFinal Results
16th Mar 20167:00 amRNSAppointment of CFO/Grant of Share Options
4th Mar 20161:25 pmRNSHolding(s) in Company
4th Mar 20167:00 amRNSTrading Update
11th Jan 20165:30 pmRNSHolding(s) in Company
29th Dec 20152:23 pmRNSHolding(s) in Company
18th Dec 201510:13 amRNSHolding(s) in Company
15th Dec 20155:25 pmRNSHolding(s) in Company
15th Dec 20155:24 pmRNSHolding(s) in Company
11th Dec 20157:00 amRNSTrading Update
3rd Dec 201511:33 amRNSBlocklisting Interim Review
1st Oct 20157:00 amRNSProgress Update on Trials
10th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSRestricted Common Shares to be Traded in CREST
20th Aug 20157:00 amRNSDirector Resignation
17th Aug 20157:00 amRNSProgress Report on Trials and Cost Reduction
29th Jul 20152:01 pmRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Statement
1st Jul 20157:00 amRNSChange of Adviser
5th Jun 20157:00 amRNSDirector/PDMR Shareholding
28th May 20159:48 amRNSBlocklisting Interim Review
21st May 20153:01 pmRNSDirector/PDMR Shareholding
19th May 20154:01 pmRNSResult of Annual Meeting
19th May 20157:00 amRNSAnnual Meeting Statement
17th Apr 20157:00 amRNSMailing of 2014 Annual Report & Notice of AGM
20th Mar 20157:00 amRNS2014 Preliminary Results
15th Jan 20155:39 pmRNSTrading Update
5th Jan 20157:00 amRNSClose of US Placing
2nd Jan 201512:00 pmRNSHolding(s) in Company
22nd Dec 201412:54 pmRNSHolding(s) in Company
10th Dec 20147:00 amRNSEquity Placing
2nd Dec 20147:00 amRNSEquity Placing
27th Nov 20143:58 pmRNSBlocklisting Interim Review
19th Nov 20147:00 amRNSTrading Statement
12th Sep 20147:00 amRNSHalf Year Results Statement
26th Aug 20147:00 amRNSMiddle East Contract Win
7th Jul 20147:00 amRNSHalf Year Trading Update & Contract Wins
13th May 20143:31 pmRNSResult of Annual Meeting
29th Apr 20144:44 pmRNSBlocklisting Interim Review
22nd Apr 201410:02 amRNSAnnual Report & Accounts Posted
20th Mar 20147:00 amRNS2013 Preliminary Results
30th Jan 20147:00 amRNSYear End Trading Update & Contract Wins
10th Dec 20133:29 pmRNSTotal Voting Rights
4th Dec 20133:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.